Women’s health-related functioning and its association with non-severe maternal morbidities during the perinatal period: an observational longitudinal study Authors: Sulin Dong, Chanya Zhang, Meiyi Chen, Xiaojiao Wang, Shangni Lan, Liping Sun, Xu Qian, Chunyi Gu Published: 2025 ABSTRACT AbstractObjectivesTo explore the levels of health-related functioning during pregnancy and postpartum and its association with non-severe maternal morbidities.DesignAn observational longitudinal study.SettingA tertiary women’s hospital in urban China.ParticipantsPregnant women in late pregnancy were recruited via consecutive sampling. The Chinese version of the Women’s Outcome Instrument for maternal healthCarE instrument was applied to measure health-related functioning and maternal morbidities at 28–41.6 weeks of gestation and at 6 weeks postpartum. Main outcome measures included health-related functioning, physical symptoms, anxiety and depression.ResultsAmong the 624 participants, health-related functioning scores were significantly higher during late pregnancy than at 6 weeks postpartum (16.33±4.78 vs 14.40±3.65, p<0.001), reflected by a marked reduction in the prevalence of severe functional impairment (from 20.5% to 11.2%). Multivariate analyses revealed that antenatal impairment was significantly associated with moderately high physical symptoms (aOR=3.618, 95% CI 1.061 to 12.354, p<0.05), mild to moderate anxiety (mild: aOR=2.986, 95% CI 1.318 to 6.767, p<0.01; moderate: aOR=7.250, 95% CI 1.076 to 48.813, p<0.05) and mild depression (aOR=3.808, 95% CI 1.652 to 8.776, p<0.01). Postnatal impairment was linked to forceps delivery (aOR=1.874, 95% CI 1.007 to 3.483, p<0.05), moderately high to high physical symptoms (moderately high: aOR=4.591, 95% CI 1.960 to 10.751, p<0.01; high: aOR=13.277, 95% CI 5.501 to 32.073, p<0.01), moderate anxiety (aOR=3.059, 95% CI 1.015 to 9.217, p<0.05) and moderate to moderately severe depression (moderate: aOR=10.538, 95% CI 3.327 to 33.415, p<0.01; moderately severe: aOR=23.453, 95% CI 1.383 to 398.218, p<0.05). A dose-response relationship was observed between the severity of antenatal impairment and postpartum morbidities (all p<0.001 for moderate and severe impairment).ConclusionFunctional impairment is prevalent perinatally and associated interactively with maternal morbidities. Assessment of health-related functioning and the provision of targeted interventions are recommended to improve maternal health outcomes in the perinatal period and beyond. STRENGTHS AND LIMITATIONS OF THIS STUDY This longitudinal study design enabled the assessment of changes in health-related functioning and non-severe maternal morbidities across the perinatal period. This longitudinal study design enabled the assessment of changes in health-related functioning and non-severe maternal morbidities across the perinatal period. The study used the previously translated and validated Chinese version of the Women’s Outcome Instrument for maternal healthCarE instrument to ensure measurement accuracy. The study used the previously translated and validated Chinese version of the Women’s Outcome Instrument for maternal healthCarE instrument to ensure measurement accuracy. The measurement of health-related functioning and maternal morbidities was limited to two time points (late pregnancy and early postpartum), precluding analysis of the full trajectory of change. The measurement of health-related functioning and maternal morbidities was limited to two time points (late pregnancy and early postpartum), precluding analysis of the full trajectory of change. The single-centre recruitment strategy may limit the generalisability of the findings to broader populations. The single-centre recruitment strategy may limit the generalisability of the findings to broader populations. Introduction The global maternal mortality ratio (MMR) in 2020 was estimated at 223 maternal deaths per 100 000 live births, a reduction from 339 in 2000, representing a decrease of one-third over the 20-year period.1 In China, the MMR dropped from 88.8 per 100 000 live births in 1990 to 15.7 in 2022.2 Maternal deaths have often been referred to as the ‘tip of the iceberg’ concerning adverse maternal health issues, while the deeper, wider issues of maternal morbidity with larger incidence rates may remain overlooked, akin to the submerged portions of an iceberg.3 Maternal morbidity encompasses the health complications experienced by women during pregnancy, childbirth and the postpartum period, which contributes to the main burden of poor maternal health.4 It is estimated that for every maternal death, 20 to 30 women suffer from morbidity.5 6 According to the WHO, maternal morbidity is defined as any health condition attributed to and/or complicating pregnancy and childbirth that negatively impacts a woman’s well-being and/or functioning.4 In recent decades, great attention has been devoted to the study of maternal mortality and severe maternal morbidity (SMM).179 However, an exclusive focus on these issues may be restrictive, as mere survival during pregnancy is no longer sufficient to achieve global targets related to maternal health.10 11 Beyond survival, the emphasis in maternal health is shifting towards promoting health and well-being throughout a woman’s life course.12 Nonetheless, many non-severe morbidities or chronic complications, such as depression, urinary and anal incontinence, and sexual dysfunction, caused or exacerbated by pregnancy and childbirth, are comparatively less visible or completely ignored.13 These conditions can have lifelong social, economic and health consequences. According to Agambodi et al,14 minor ailments during pregnancy are not trivial concerns for pregnant women, unfolding that nine out of ten women reported at least one episode of ill health during pregnancy, and 60% of women were unable to perform their daily and work-related activities due to health issues. Mota et al found that 57.7% of women with low back pain had limited daily activities, and 77.5% of these women reported worsening conditions as pregnancy progressed.15 Another cross-sectional study conducted in China showed that women with physical comorbidities were more likely to experience depression, and those with depression reported a lower quality of life across physical, psychological, social and environmental domains.16 Health-related functioning refers to all bodily functions, both physical and cognitive, as well as activities and participation.17 Functioning and disability represent two pertinent domains within this construct.18 Indicators of functional status serve as robust predictors of health events, with the predictive power of disability often surpassing that of clinical diagnoses in various chronic conditions.18 19 Thus, assessment of functioning and disability is crucial for understanding the relationship between individuals and morbidity. Given that pregnancy, childbirth and the lived experiences of the postnatal period can independently affect health, social and economic functioning and well-being,17 there is an increasing recognition of the necessity to evaluate functioning and well-being in relation to health conditions, including non-severe maternal morbidities. To accurately measure non-severe maternal morbidity, the WHO Maternal Morbidity Working Group has developed a standardised instrument known as the Women’s Outcome Instrument for maternal healthCarE (WOICE).4 The WOICE instrument emphasises a comprehensive assessment of women’s health and well-being during both pregnancy and the postpartum period.4 20 21 This tool aims to identify women experiencing non-severe maternal morbidities, thereby enabling health professionals to gain a broader understanding of women’s health beyond clinical diseases and to provide adequate care for often-overlooked conditions during routine healthcare.4 6 A pilot study using the WOICE tool was conducted in Jamaica, Kenya and Malawi among pregnant women (approximately 28 weeks gestation) and postpartum women (between 6 and 12 weeks),21 22 revealing a high prevalence of non-severe morbidity in these countries. Hababa and Assarag applied the WOICE questionnaires in Morocco to assess non-severe maternal morbidities in both pregnant and postpartum women, finding that 39.69% of pregnant women reported a medical condition,23 while 9.09% of postpartum women had a health condition documented by the attending physician.24 Lamus et al conducted a survey using the WOICE tool in southeastern Brazil, discovering that around one-third of high-risk postpartum women reported health problems identified by their physician and that poor overall health ratings were associated with increased anxiety/depression and impaired functioning.25 In the international community, there has been a growing interest in understanding and measuring maternal morbidity and health functioning within a broader context.3 4 24 26 However, the extent of functional impairment and its relationship with non-severe morbidities remains less well understood among the Chinese population, which is characterised by a large annual birth cohort and a rapidly evolving healthcare system. Moreover, standardised instruments for measuring women’s overall maternal morbidities are underused in the country. Therefore, by applying the translated Chinese version of the WHO-WOICE tool, the aim of this study was to investigate the level of health-related functioning during the pregnancy and postpartum periods, as well as to analyse the association between health-related functioning and non-severe maternal morbidities among Chinese women. Method Study design We conducted an observational longitudinal study at a large tertiary hospital in urban China. The recruitment period, during which eligible pregnant women were enrolled and completed their baseline (T1) assessment, spanned from 1 September 2020 to 31 July 2021. The overall study period, which included the recruitment phase and the subsequent 6-week postpartum follow-up for all participants, extended from 1 September 2020 to 30 November 2021. Study setting The study was carried out at the Obstetrics and Gynecology Hospital of Fudan University, a tertiary-care women’s specialty hospital in Shanghai, China. This facility comprises two campuses (Huangpu and Yangpu) and handles an annual delivery volume of approximately 10 000 births, reflecting a large and diverse catchment population. Pregnant women receive routine perinatal care from obstetricians and nurse midwives at this institution, and they are advised to return for a postnatal outpatient visit at 6 weeks after childbirth. During the recruitment period, a total of 4629 eligible pregnant women attended the antenatal clinics at the study hospital. Participants Eligible participants were recruited from the antenatal clinics of the study hospital using a non-probability, consecutive sampling method. This method was selected as the most feasible strategy for this single-centre longitudinal study, aiming to enrol a representative cohort of women from the hospital’s population while ensuring efficient recruitment and follow-up. The inclusion criteria for our study were as follows: (1) pregnant women (≥18 years) with a singleton pregnancy; (2) between 28 and 41.6 gestational weeks; and (3) Mandarin speakers capable of speaking, reading and writing in Chinese. The exclusion criteria included (1) participants with cognitive impairments or communication challenges and (2) those who declined to participate in the study. Sample size determination The sample size was calculated a priori using the formula for the McNemar paired χ2 test.27 The calculation was based on the outcome of urinary incontinence, a prevalent maternal morbidity, observed in our pilot study (n=66), which found that 16.67% of women experienced symptoms only during pregnancy (P1) and 10.61% experienced symptoms only postpartum (P2). With α set at 0.05 (two-sided) and power (1-β) at 0.80, the minimum required sample size was determined to be 581 women. To account for an anticipated 5% loss to follow-up, the final targeted sample size was adjusted to 612 participants. This calculation ensured sufficient power for detecting changes in this primary binary outcome. Although the sample size was not specifically calculated for all analytical methods employed in the study (eg, correlation analyses and multivariate regression), our final sample (n=624) provided robust data for the key associations investigated. Measurement tools Data were collected using the Chinese version of the WOICE instrument, which has demonstrated good reliability, with Cronbach’s α values of 0.780 for antenatal and 0.875 for postnatal questionnaires in previous validation studies.28 29 Key outcome variables were assessed at two time points: during late pregnancy (T1, 28–41.6 weeks gestation) and at 6 weeks postpartum (T2). The WOICE tool consists of two parts: personal history and personal antenatal/postnatal symptoms. Part 1 includes socio-demographic information, obstetric history, sexual life and risk factors/environment. Part 2 consists of four subscales used to measure the key outcomes of this study: the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), self-reported Physical Symptoms related to Maternal Morbidities (PSMM), the Generalized Anxiety Disorder 7-item scale (GAD-7) and the Patient Health Questionnaire 9-item scale (PHQ-9). Health-related functioning Health-related functioning encompasses all bodily functions, including both physical and cognitive aspects, as well as activities and participation.17 It reflects an individual’s ability to perform daily activities and engage in life situations over the past 30 days. In our study, health-related functioning was assessed using the 12-item WHODAS 2.0 subscale (for short) within the WOICE instrument. This subscale includes six primary domains: cognition, mobility, self-care, getting along with people, life activities and participation in society.30 Each item is rated on a 5-point scale of difficulty (1=none; 2=mild; 3=moderate; 4=severe; and 5=extreme or cannot do). The total score, which ranges from 12 to 60, was calculated, with higher scores indicating greater functional impairment. For analytical purposes, total scores were categorised into four levels of impairment based on quartiles: none (12 points), mild (13–14), moderate (15–19) and severe (≥20). Non-severe maternal morbidities Maternal morbidity refers to any health condition attributed to and/or complicating pregnancy and childbirth that negatively impacts a woman’s well-being and/or functioning.4 This study specifically focused on non-severe morbidities, which include: Physical symptoms: This category encompasses a broad range of self-reported health issues that women have experienced physically in the past 2 weeks (eg, nausea, back pain, incontinence). In our study, we evaluated these symptoms using the PSMM subscale of the WOICE. The PSMM subscale includes over 62 physical symptoms. Participants were asked to indicate the presence (‘Yes’) or absence (‘No’) of each symptom. The total number of reported symptoms was aggregated and classified as follows: low (1–3), moderate (4–6), moderately high (7–11), or high (≥12). Physical symptoms: This category encompasses a broad range of self-reported health issues that women have experienced physically in the past 2 weeks (eg, nausea, back pain, incontinence). In our study, we evaluated these symptoms using the PSMM subscale of the WOICE. The PSMM subscale includes over 62 physical symptoms. Participants were asked to indicate the presence (‘Yes’) or absence (‘No’) of each symptom. The total number of reported symptoms was aggregated and classified as follows: low (1–3), moderate (4–6), moderately high (7–11), or high (≥12). Anxiety: Anxiety disorders are the most prevalent mental health conditions, particularly during the perinatal period, which spans from conception to 12 months postpartum. In this study, anxiety was measured using the GAD-7 subscale of the WOICE instrument. Participants rated the frequency of each symptom experienced over the past 2 weeks on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). Total scores were summed, with possible values ranging from 0 to 21, and categorised into four levels of severity: minimal (0–4), mild (5–9), moderate (10–14) and severe (15–21), based on established cut-off scores.31 Anxiety: Anxiety disorders are the most prevalent mental health conditions, particularly during the perinatal period, which spans from conception to 12 months postpartum. In this study, anxiety was measured using the GAD-7 subscale of the WOICE instrument. Participants rated the frequency of each symptom experienced over the past 2 weeks on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). Total scores were summed, with possible values ranging from 0 to 21, and categorised into four levels of severity: minimal (0–4), mild (5–9), moderate (10–14) and severe (15–21), based on established cut-off scores.31 Depression: Perinatal depression includes both major and minor depressive episodes that occur during pregnancy (antenatal depression) or within 12 months postpartum (postnatal depression). This construct was assessed using the PHQ-9, a reliable and widely used subscale of the WOICE instrument. Respondents rated the frequency of each of the nine depressive symptoms experienced over the past 2 weeks on a scale from 0 (not at all) to 3 (nearly every day). The total scores, which range from 0 to 27, were interpreted using standard thresholds: minimal (0–4), mild (5–9), moderate (10–14), moderately severe (15–19) and severe (20-27).32 Depression: Perinatal depression includes both major and minor depressive episodes that occur during pregnancy (antenatal depression) or within 12 months postpartum (postnatal depression). This construct was assessed using the PHQ-9, a reliable and widely used subscale of the WOICE instrument. Respondents rated the frequency of each of the nine depressive symptoms experienced over the past 2 weeks on a scale from 0 (not at all) to 3 (nearly every day). The total scores, which range from 0 to 27, were interpreted using standard thresholds: minimal (0–4), mild (5–9), moderate (10–14), moderately severe (15–19) and severe (20-27).32 Data collection procedures This longitudinal study involved data collection at two key time points: baseline (T1) during late pregnancy and endline (T2) at 6 weeks postpartum. The baseline assessment was conducted at 28–41.6 weeks of gestation, a period chosen as it represents the third trimester when pregnancy-related discomfort and functional limitations are often most pronounced. The endline assessment was scheduled for 6 weeks postpartum, coinciding with the routine postnatal check-up in China. This timing maximises follow-up participation rates and allows for the assessment of recovery and early postpartum morbidities. Two obstetric nurses were trained as investigators for this study. Eligible participants were invited to complete the questionnaires via an online follow-up platform. At the first time point (T1), consented women independently completed the WOICE-antenatal questionnaire. At the second time point (T2), participants filled out the WOICE-postnatal questionnaire at the postnatal clinic of the study hospital. Data on the women’s sociodemographic information, obstetric history, modes of delivery, childbirth outcomes and breastfeeding were obtained through chart reviews. The main outcomes for analysis were health-related functioning, physical symptoms, anxiety and depression during late pregnancy and at 6 weeks postpartum. Other variables included the women’s sociodemographic characteristics and maternal clinical information. Data analysis Statistical analyses were performed using SPSS Statistics Version 26.0. Descriptive statistical analysis was performed on women’s basic characteristics including sociodemographic information, pregnancy history, sexual life, self-reported types and numbers of physical symptoms during late pregnancy and postpartum maternal morbidities, as well as the scale scores of the WHODAS 2.0, GAD-7 and PHQ-9. For continuous variables, the Shapiro-Wilk test was used to assess normality. Normally or nearly normally distributed variables were described by means and SD, while non-normally distributed variables were described by their extreme values (Min-Max), medians (M) and interquartile ranges (P25–P75). Categorical variables were analysed by numbers and frequencies. Statistical significance was set at a P value <0.05. To perform variance analysis, the t-test or paired t-test was used for variables with normal or approximately normal distributions; the Wilcoxon matched-pairs test was applied for non-normally distributed variables; and the χ2 test or McNemar paired χ2 test was applied for categorical data. To complement the primary analysis and better capture the within-individual changes between the two time points, paired analyses were conducted. The changes in total WHODAS 2.0 scores and its domain scores from late pregnancy to postpartum were analysed using the Wilcoxon signed-rank test for paired data. Changes in the proportions of women across functional impairment categories were assessed using McNemar’s test. In our study, correlation analyses were conducted to identify associations between health-related functioning and self-reported physical symptoms, as well as anxiety and depression scores, both during late pregnancy and at 6 weeks postpartum. Spearman’s correlation analysis was applied to continuous variables that were not normally distributed and to bidirectional ordinal categorical data with identical properties, while the Goodman-Kruskal Gamma method was used for data with bidirectional ordinal categories and different properties. To identify the association between explanatory variables and health-related functioning, we conducted multiple logistic regression or ordinal logistic regression analyses based on the nature of the dependent variables. The crude OR (cOR), adjusted OR (aOR) and 95% CIs were calculated accordingly. Prior to conducting logistic regression analyses, the assumptions of the models were tested. Multicollinearity among independent variables was assessed using Variance Inflation Factors (VIFs), with a VIF of <5 indicating no significant multicollinearity. The goodness-of-fit of the models was evaluated using the Hosmer-Lemeshow test, where a P value >0.05 indicates a good fit. To explore the longitudinal association between antenatal health-related functioning and postpartum maternal morbidity (including postpartum physical symptoms, anxiety, depression and health-related functioning), we employed linear mixed-effects models for analysis. Quality assurance To ensure data accuracy, completeness and consistency, a comprehensive quality assurance protocol was implemented throughout the study. Structured instruments: We used the validated WOICE instrument, applying its subscales with pre-defined recall periods (eg, 30 days for the WHODAS 2.0 and 2 weeks for the PSMM, GAD-7 and PHQ-9), to enhance measurement precision and minimise recall bias. Structured instruments: We used the validated WOICE instrument, applying its subscales with pre-defined recall periods (eg, 30 days for the WHODAS 2.0 and 2 weeks for the PSMM, GAD-7 and PHQ-9), to enhance measurement precision and minimise recall bias. Standardised training: All research personnel, including the two obstetric nurses serving as investigators and the two research nurses responsible for supervision, underwent a mandatory 1 day standardised training session. This training covered the study protocol, inclusion/exclusion criteria, detailed review of all questionnaire items and standardised scripts for participant instruction and consent acquisition. In addition, refresher sessions were held bi-monthly to address any questions, reinforce protocols and prevent procedural drift. Standardised training: All research personnel, including the two obstetric nurses serving as investigators and the two research nurses responsible for supervision, underwent a mandatory 1 day standardised training session. This training covered the study protocol, inclusion/exclusion criteria, detailed review of all questionnaire items and standardised scripts for participant instruction and consent acquisition. In addition, refresher sessions were held bi-monthly to address any questions, reinforce protocols and prevent procedural drift. Real-time guidance and data verification: Investigators provided clear instructions to participants on completing the questionnaires, offering assistance either on-site or remotely via online guidance for those who completed the questionnaire at home. Research nurses checked all questionnaires for completeness and logical consistency immediately on completion. Forms with missing items or inconsistencies were promptly returned to participants for clarification. This proactive approach significantly reduced errors and potential recall decay. Real-time guidance and data verification: Investigators provided clear instructions to participants on completing the questionnaires, offering assistance either on-site or remotely via online guidance for those who completed the questionnaire at home. Research nurses checked all questionnaires for completeness and logical consistency immediately on completion. Forms with missing items or inconsistencies were promptly returned to participants for clarification. This proactive approach significantly reduced errors and potential recall decay. Data management: All data were independently double-entered into the EpiData database by two research nurses. The resulting datasets were electronically compared, and any discrepancies were meticulously resolved through adjudication against the original source documents. Data management: All data were independently double-entered into the EpiData database by two research nurses. The resulting datasets were electronically compared, and any discrepancies were meticulously resolved through adjudication against the original source documents. Pilot testing: A pilot survey was conducted prior to the main investigation to assess feasibility, estimate symptom prevalence for sample size calculation and identify ambiguities in the instrument or procedures. Based on the feedback from the pilot, minor adjustments were made to participant instructions to enhance clarity. Pilot testing: A pilot survey was conducted prior to the main investigation to assess feasibility, estimate symptom prevalence for sample size calculation and identify ambiguities in the instrument or procedures. Based on the feedback from the pilot, minor adjustments were made to participant instructions to enhance clarity. Ethical considerations Ethical approval was obtained from the Medical Research Ethics Committee of the School of Public Health, Fudan University (No. IRB#2021-02-0878). Permission to carry out the research was granted by the heads of the obstetrics and nursing departments at the participating health facility. All potential participants were recruited from the antenatal clinic and provided with written information about the study before giving their signed consent. Participants who met the inclusion criteria provided written informed consent prior to the commencement of data collection. To ensure participant privacy, all data were anonymised. Patient and public involvement Patients or the public were not involved in the design, conduct, reporting or dissemination plans of this research. Results Characteristics of the participants A total of 722 pregnant women were initially enrolled during late pregnancy. Among these participants, 98 women withdrew from the study by 6 weeks postpartum, yielding a loss to follow-up rate of 13.57% (98/722). Ultimately, 624 women completed valid questionnaires both in late pregnancy and at 6 weeks postpartum. There were no statistically significant differences between the follow-up group and the loss to follow-up group regarding maternal age, ethnicity, occupational type, marital status and whether the pregnancy was planned (all p>0.05). The proportions of rural residents (χ2=6.022, p=0.019) and individuals with high school education or below (χ2=11.578, p=0.021) were significantly higher in the loss to follow-up group compared with the follow-up group. No missing data were present for outcome variables, and thus complete-case analysis was performed for all 624 participants. The participants’ ages ranged from 19 to 39 years, with a mean age of 29.36±3.05 years. The mean gestational week at admission for this study was 32.92±3.74 weeks. Participants’ sociodemographic and clinical characteristics are presented in table 1. Table 1Characteristics of the participants (n=624)VariablesNumber (n)Percentage (%)Age (years) (mean±SD)29.36±3.05Educational level Junior high school and below111.76 Senior high school213.37 College42868.59 Undergraduate15625.00 Master and above81.28Gestational age at admission (weeks) (mean±SD)32.92±3.74Pre-pregnancy BMI (kg/m2) (mean±SD)21.34±2.98 Underweight (<18.5)619.78 Normal weight (18.5~23.9)47676.27 Overweight (24.0~27.9)6710.74 Obese (≥28.0)203.21Postpartum BMI (kg/m2) (mean±SD)22.62±2.61 Underweight (<18.5)162.56 Normal weight (18.5~23.9)43469.56 Overweight (24.0~27.9)15825.32 Obese (≥28.0)162.56Parity Primiparous56290.06 Multiparous629.94History of abortion No47876.60 Yes14623.40Attending midwife antenatal clinic No27143.43 Yes35356.57Pregnancy complications GDM629.94 Gestational hypertension284.49 Anaemia6610.58 Other morbidities101.60 No complications47275.64Gestational age of delivery (weeks) (mean±SD)39.07±1.22 <37172.72 ≥3760797.28Mode of delivery Spontaneous vaginal delivery42467.95 Forceps delivery457.21 Caesarean delivery15524.84Health status during delivery Healthy mother and newborn49879.81 Neonatal complication10817.31 Maternal complication142.24 Maternal/neonatal complication40.64Antenatal sexual life No31350.16 Yes31149.84Antenatal substance abuse No61698.72 Yes81.28Antenatal exposure to violence No60396.63 Yes213.37Sexual life at 6 weeks postpartum No52684.29 Yes9815.71Substance abuse at 6 weeks postpartum No61999.20 Yes50.80Exposure to violence at 6 weeks postpartum No447.05 Yes58092.95Breastfeeding at 6 weeks postpartum No396.25 Yes58593.75BMI, body mass index; GDM, gestational diabetes mellitus; SD, standard deviation. Characteristics of the participants (n=624) BMI, body mass index; GDM, gestational diabetes mellitus; SD, standard deviation. Antenatal and postnatal health-related functioning Health-related functioning scores were significantly higher during late pregnancy than at 6 weeks postpartum (16.33±4.78 vs 14.40±3.65, p<0.001) (table 2). Wilcoxon signed-rank tests confirmed that all WHODAS 2.0 domains (cognition, mobility, self-care, getting along with people, life activities and participation) scored significantly higher during pregnancy than postpartum (all p<0.01). Based on quartiles of the total functioning scores, women were categorised into four levels of impairment: no impairment (12 points), mild impairment (13–14 points), moderate impairment (15–19 points) and severe impairment (≥20 points). During late pregnancy, the proportions of women in these categories were 25.0% (156/624), 21.5% (134/624), 33.0% (206/624) and 20.5% (128/624), respectively. At 6 weeks postpartum, the proportion with no impairment increased to 47.0% (293/624), with 21.8% (136/624), 20.0% (125/624) and 11.2% (70/624) experiencing mild, moderate and severe impairment, respectively. Table 2Health-related functioning during late pregnancy and at 6 weeks postpartum (n=624)WHODAS 2.0 domainHealth-related functioning during late pregnancy (mean±SD)Health-related functioning at 6 weeks postpartum(mean±SD)Z statisticP valueCognition2.59±0.962.42±0.964.6290.001Mobility3.21±1.362.59±0.959.934< 0.001Self-care2.50±0.912.05±0.2811.722< 0.001Getting along with people2.23±0.722.12±0.574.1930.002Life activities2.75±1.082.57±0.994.0460.001Participation3.05±1.232.70±1.196.828<0.001Total 16.33±4.78 14.40±3.65 10.066 <0.001 Note: Data presented as mean±SD. Comparisons between time points were performed using the Wilcoxon matched-pairs signed-rank test; the Z statistic is the standardised test statistic for this non-parametric test. Health-related functioning during late pregnancy and at 6 weeks postpartum (n=624) Note: Data presented as mean±SD. Comparisons between time points were performed using the Wilcoxon matched-pairs signed-rank test; the Z statistic is the standardised test statistic for this non-parametric test. Association between health-related functioning and non-severe maternal morbidity Gamma correlation analysis revealed significant associations between health-related functional impairment and the severity of non-severe maternal morbidities. During late pregnancy, higher levels of functional impairment correlated with more physical symptoms (G=0.286, p<0.001), higher anxiety scores (G=0.575, p<0.001), and greater depression (G=0.622, p<0.001). Prior to multivariate modelling, diagnostic checks confirmed that the assumptions of the ordinal regression model were met, with no evidence of multicollinearity among predictors. Multivariate logistic regression analysis further identified that women reporting moderately high physical symptoms had significantly elevated odds of functional impairment (aOR=3.618, 95% CI 1.061 to 12.354, p<0.05). Mild (aOR=2.986, 95% CI 1.318 to 6.767, p<0.01) and moderate (aOR=7.250, 95% CI 1.076 to 48.813, p<0.05) anxiety, as well as mild depression (aOR=3.808, 95% CI 1.652 to 8.776, p<0.01), were also associated with higher levels of functional impairment. At 6 weeks postpartum, health-related functioning remained significantly correlated with physical symptoms (G=0.575, p<0.001), anxiety (G=0.661, p<0.001) and depression (G=0.720, p<0.001). Forceps delivery was associated with higher odds of functional impairment compared with spontaneous vaginal delivery (aOR=1.874, 95% CI 1.007 to 3.483, p<0.05). Postpartum women with moderately high (aOR=4.591, 95% CI 1.960 to 10.751, p<0.01) or high physical symptoms (aOR=13.277, 95% CI 5.501 to 32.073, p<0.01), moderate anxiety (aOR=3.059, 95% CI 1.015 to 9.217, p<0.05) and moderate (aOR=10.538, 95% CI 3.327 to 33.415, p<0.01) or moderately severe depression (aOR=23.453, 95% CI 1.383 to 398.218, p<0.05) were at an increased risk of functional impairment (table 3). Table 3Logistic regression analyses of factors affecting women’s health-related functioningVariableSubgroupHealth-related functioning during late pregnancy (n=624)Health-related functioning at 6 weeks postpartum (n=624)cOR (95% CI)aOR (95% CI)cOR (95% CI)aOR (95% CI)Multiparous women0.964 (0.602 to 1.543)1.254 (0.457 to 3.442)0.634 (0.382 to 1.050)0.770 (0.410 to 1.443)History of abortion0.906 (0.649 to 1.264)1.203 (0.668 to 2.166)1.058 (0.751 to 1.489)1.091 (0.736 to 1.616)Having sexual life1.031 (0.778 to 1.367)1.470 (0.882 to 2.450)0.571 (0.376 to 0.868)**0.616 (0.378 to 1.005)Substance abuse2.442 (0.680 to 8.767)0.161 (0.010 to 2.680)1.480 (0.301 to 7.272)2.264 (0.326 to 15.690)Exposure to violence7.614 (3.117 to 18.596)**1.811 (0.443 to 7.411)2.751 (1.581 to 4.792)**1.416 (0.748 to 2.680)Physical symptomsLow (1-3) symptom1.274 (0.688 to 2.358)1.428 (0.464 to 4.393)1.904 (0.786 to 4.614)1.565 (0.629 to 3.896)Moderate (4-6) symptom1.885 (1.008 to 3.522)*1.852 (0.576 to 5.954)2.430 (1.033 to 5.726)*2.143 (0.891 to 5.155)Moderately high (7-11) symptom3.497 (1.809 to 6.760)** 3.618 (1.061 to 12.354)* 6.153 (2.686 to 14.083)** 4.591 (1.960 to 10.751)** High (≥12) symptom5.145 (2.361 to 11.212)**2.509 (0.530 to 11.870)25.432 (10.892 to 59.323)** 13.277 (5.501 to 32.073)** AnxietyMild (5-9)4.473 (2.986 to 6.693)** 2.986 (1.318 to 6.767)** 5.755 (3.751 to 8.820)**1.714 (0.988 to 2.974)Moderate (10-14)12.049 (4.088 to 35.517)** 7.250 (1.076 to 48.813)* 18.102 (7.478 to 43.860)** 3.059 (1.015 to 9.217)* Severe (≥15)——33.315 (6.719 to 165.009)**1.828 (0.208 to 16.055)DepressionMild (5-9)5.089 (3.442 to 7.523)** 3.808 (1.652 to 8.776)** 5.360 (3.404 to 8.440)**1.714 (0.988 to 2.974)Moderate (10-14)12.170 (4.591 to 32.266)**1.164 (0.158 to 8.585)51.367 (19.453 to 135.775)** 10.538 (3.327 to 33.415)** Moderately severe (15-19)——87.970 (9.786 to 790.764)** 23.453 (1.383 to 398.218)* GDM0.779 (0.486 to 1.249)0.547 (0.220 to 1.363)——Antenatal anaemia1.657 (1.041 to 2.635)*1.022 (0.434 to 2.404)——Hypertension during pregnancy0.748 (0.378 to 1.478)0.960 (0.210 to 4.380)——Mode of deliveryForceps delivery——2.818 (1.616 to 4.918)** 1.874 (1.007 to 3.483)* Caesarean delivery——1.030 (0.732 to 1.451)0.899 (0.609 to 1.324)Health status during deliveryNeonatal complication——1.545 (1.057 to 2.257)*1.486 (0.967 to 2.284)Maternal complication——3.068 (1.179 to 7.980)*2.111 (0.746 to 5.977)Maternal/neonatal complication——0.634 (0.091 to 4.419)0.461 (0.061 to 3.487)Breastfeeding——1.235 (0.671 to 2.273)1.003 (0.489 to 2.061)**p< 0.01; *p< 0.05; “—” not applicable; Health-related functioning: none, y=0; mild, y=1; moderate, y=2; severe, y=3. Parity: primiparous women, x1=0 (reference); multiparous women, x2=1. History of abortion: no, x1=0 (reference); yes, x2=1. Having a sexual life: no, x1=0 (reference); yes, x2=1. Substance abuse: no, x1=0 (reference); yes, x2=1. Exposure to violence: no, x1=0 (reference); yes, x2=1. Physical symptoms: none, x1=0 (reference); low, x2=1; moderate, x3=2; moderately high, x4=3; high, x5=4. Anxiety: none, x1=0 (reference); mild, x2=1; moderate, x3=2; severe, x4=3. Depression: none, x1=0 (reference); mild, x2=1; moderate, x3=2; moderately severe, x4=3. GDM: no, x1=0 (reference); yes, x2=1. Antenatal anaemia: no, x1=0 (reference); yes, x2=1. Hypertension during pregnancy: no, x1=0 (reference); yes, x2=1. Mode of delivery: spontaneous vaginal delivery, x1=0 (reference); forceps delivery, x2=1; caesarean delivery, x3=2. Health status during delivery: healthy, x1=0 (reference); neonatal complication, x2=1; maternal complication, x3=2; maternal/neonatal complication, x4=3. Breastfeeding: no, x1=0 (reference); yes, x2=1.Bold values indicate statistically significant adjusted odds ratios (aOR) (p < 0.05), representing significant associations after controlling for covariates.aOR, adjusted OR; cOR, crude OR; GDM, gestational diabetes mellitus. Logistic regression analyses of factors affecting women’s health-related functioning **p< 0.01; *p< 0.05; “—” not applicable; Health-related functioning: none, y=0; mild, y=1; moderate, y=2; severe, y=3. Parity: primiparous women, x1=0 (reference); multiparous women, x2=1. History of abortion: no, x1=0 (reference); yes, x2=1. Having a sexual life: no, x1=0 (reference); yes, x2=1. Substance abuse: no, x1=0 (reference); yes, x2=1. Exposure to violence: no, x1=0 (reference); yes, x2=1. Physical symptoms: none, x1=0 (reference); low, x2=1; moderate, x3=2; moderately high, x4=3; high, x5=4. Anxiety: none, x1=0 (reference); mild, x2=1; moderate, x3=2; severe, x4=3. Depression: none, x1=0 (reference); mild, x2=1; moderate, x3=2; moderately severe, x4=3. GDM: no, x1=0 (reference); yes, x2=1. Antenatal anaemia: no, x1=0 (reference); yes, x2=1. Hypertension during pregnancy: no, x1=0 (reference); yes, x2=1. Mode of delivery: spontaneous vaginal delivery, x1=0 (reference); forceps delivery, x2=1; caesarean delivery, x3=2. Health status during delivery: healthy, x1=0 (reference); neonatal complication, x2=1; maternal complication, x3=2; maternal/neonatal complication, x4=3. Breastfeeding: no, x1=0 (reference); yes, x2=1. Bold values indicate statistically significant adjusted odds ratios (aOR) (p < 0.05), representing significant associations after controlling for covariates. aOR, adjusted OR; cOR, crude OR; GDM, gestational diabetes mellitus. Impact of antenatal health-related functioning on postpartum maternal morbidity Linear mixed-effects models further demonstrated that higher levels of antenatal functional impairment were significantly associated with worse postpartum outcomes. Severe antenatal impairment was consistently associated with worse postpartum physical symptoms, anxiety, depression and health-related functioning (all p<0.001). Associations for moderate impairment were also significant across all outcomes (all p<0.001), while mild impairment showed statistically significant associations with depression (β=0.614, 95% CI 0.020 to 1.208, p=0.043) and health-related functioning (β=1.522, 95% CI 1.052 to 1.993, p<0.001), but not with physical symptoms (p=0.343) or anxiety (p=0.176) (table 4). Supporting these findings, Spearman correlation analysis confirmed a positive correlation between antenatal and postpartum functioning scores (r=0.311, p<0.001). Table 4Linear mixed-effects models examining the association between antenatal health-related functioning and postpartum maternal morbidityVariableSubgroupPostpartum physical symptomsPostpartum anxietyPostpartum depressionPostpartum health-related functioningβ (95% CI) P value β (95% CI) P value β (95% CI) P value β (95% CI) P value Antenatal health-related functioningIntercept3.699 (3.086 to 4.311)<0.0011.051 (0.654 to 1.449)<0.0011.147 (0.743 to 1.551)<0.00112.000 (11.680 to 12.320)<0.001No impairment(12)ref—ref—ref—ref—Mild impairment (13–14)0.436 (−0.466 to 1.337)0.3430.404 (-0.181 to 0.989)0.1760.614 (0.020 to 1.208)0.0431.522 (1.052 to 1.993)<0.001Moderate impairment(15–19)1.631 (0.819 to 2.444)<0.0011.434 (0.907 to 1.961)<0.0012.081 (1.545 to 2.616)<0.0014.607 (4.183 to 5.030)<0.001Severe impairment (≥20)3.270 (2.357 to 4.183)<0.0013.527 (2.934 to 4.119)<0.0014.079 (3.477 to 4.681)<0.00112.078 (11.602 to 12.554)<0.001 Linear mixed-effects models examining the association between antenatal health-related functioning and postpartum maternal morbidity Discussion Our study provides a snapshot of maternal health at two pivotal moments in the perinatal period: the peak of physical demand in late pregnancy and the conventional endpoint of ‘postpartum recovery’ at 6 weeks. In this observational longitudinal study, we found that functional impairment is highly prevalent among women in urban China during both late pregnancy and the early postpartum period, with varying degrees of severity. Notably, while functioning improved significantly from pregnancy to postpartum, a substantial burden of impairment persisted. Importantly, health-related functioning was significantly correlated with non-severe maternal morbidities, including physical symptoms, anxiety and depression. Women with antenatal functional impairment were at a higher risk of postpartum functional impairment and other maternal health issues. These findings highlight the need to integrate standardised assessments of health-related functioning into routine perinatal care and to develop tailored interventions for affected women. Pregnancy and the postpartum period are often viewed as normal physiological processes; however, they substantially impact health-related functioning, which reflects a woman’s ability to perform activities and results from a dynamic interaction between maternal health conditions and contextual factors.26 33 34 In this study, over half of the pregnant women (53.5%) and nearly one-third of postpartum women (31.2%) experienced moderate to severe functional impairment, underscoring the commonality of this issue and its persistence beyond childbirth.35 The higher level of functional impairment during pregnancy compared with the postpartum period is consistent with previous studies conducted in international settings, which also reported greater functional limitations during antenatal periods.26 36 During pregnancy, particularly in the third trimester, a combination of physiological and immunological changes, along with the mother’s enlarged uterus and the developing foetus, can lead to alterations in both physical and emotional symptoms,37 38 thus significantly contributing to functional impairment. The postnatal period represents a critical transitional phase that sets the stage for the long-term health and well-being of both the mother and her infant.39 This period can present considerable challenges for the mother, including physical recovery, newborn care, sleep deprivation and emotional adjustment.3941 However, it is noteworthy that the postnatal period is often the most neglected phase in the lives of mothers and newborn infants, receiving less attention from care providers than pregnancy and childbirth.39 42 43 Therefore, assessing and supporting health-related functioning throughout the perinatal continuum is essential from both clinical and public health perspectives. Our analysis further revealed that functional impairment is multifactorial. Specifically, we found strong associations between health-related functioning and physical symptoms, such as back pain, decreased exercise tolerance and abnormal urination, especially when women experienced seven or more symptoms. These results align with existing literature that links physical morbidity to functional limitations.34 44 45 Additionally, our study revealed that the mode of delivery influences functional status, with forceps vaginal delivery associated with higher impairment, likely due to its correlation with perineal trauma, pelvic floor dysfunction and prolonged recovery.4648 Thus, it is evident that the presence of maternal physical health problems may directly limit women’s functions and also contribute to deteriorating maternal emotional health. Mental health plays a critical role in the perinatal period. In this study, we found that women with symptoms of anxiety or depression were significantly more likely to experience functional impairment. This association may be driven by profound physical, emotional and psychological changes occurring during the perinatal period, alongside the high prevalence of mental health issues.49 50 Perinatal mental health conditions can co-occur and interact, thereby exacerbating their negative impact on health-related functioning and overall well-being.51 52 Similarly, other researchers have reported that maternal anxiety and depression are primary factors affecting the quality of life in pregnant women,44 and that poor overall health ratings are associated with increased anxiety and depression, as well as impaired functioning.25 The magnitude of these associations is not only statistically significant but also clinically meaningful. For instance, the adjusted OR of 2.986 for mild anxiety indicates a nearly threefold increase in risk, highlighting a clinically meaningful association that necessitates the integration of mental health screening into routine perinatal care. As such, addressing perinatal anxiety and depression through appropriate interventions can help mitigate their adverse effects on health-related functioning. Taken together, these findings indicate that health-related functioning is a central component of perinatal well-being, influenced by a range of biopsychosocial factors. According to Cresswell et al,26 functioning is a critical concept that integrates a woman-centred approach to examining how health conditions affect women’s lives and their subsequent return to functioning after delivery. In our study, pregnant women exhibited higher levels of functional impairment in late pregnancy due to multimorbidities related to physical symptoms, anxiety and depression. These maternal health conditions during pregnancy may further reduce functioning levels, potentially persisting and impacting postpartum recovery. Meanwhile, several interconnected determinants, such as maternal characteristics, modifiable risk factors and the quality of antenatal care,53 have been reported to influence perinatal health functioning. As Chaudhuri and Mandal noted, maternal health and well-being during pregnancy can predict future public health challenges that healthcare systems must address.54 The clinical and public health implications of our findings are substantial. To translate these results into practice, China’s perinatal care model must evolve beyond a sole focus on physical outcomes to incorporate standardised assessments of functioning and mental health. This evolution could involve embedding validated tools into digital health systems at critical junctures, facilitating the early identification of at-risk women who could benefit from a stepped-care model of support. Concurrently, the significant burden of postpartum functional impairment highlights the urgent need to expand the scope and duration of postnatal services. Public health efforts should prioritise extending structured support beyond the conventional 6-week period and mandate comprehensive training for healthcare providers to enhance their capacity in managing the full spectrum of maternal morbidities, ultimately promoting a woman-centred care model that values overall well-being. While limited to two time points, our findings illuminate significant changes and associations between late pregnancy and the early postpartum window. They establish a critical baseline from which future research, employing more dense longitudinal sampling (eg, across trimesters and extending to 6 or 12 months postpartum), can build to fully characterise the dynamics of maternal morbidity and recovery. Strengths and limitations A primary strength of this study lies in its pioneering application of the translated WOICE instrument within a Chinese population. This, combined with its prospective longitudinal design, facilitates a novel examination of the interrelationships between health-related functioning and non-severe maternal morbidities. However, several limitations should be considered. First, the use of non-probability sampling at a single urban tertiary hospital limits the generalisability of our findings to the broader Chinese population, although consecutive recruitment enhances representativeness within the setting. Additionally, a higher loss to follow-up among participants from rural areas or with lower educational attainment may further exacerbate selection bias. Second, while reliance on self-reported data is appropriate for measuring subjective experiences, future studies should incorporate objective clinical measures for a more comprehensive assessment. Third, measurements taken at only two time points (late pregnancy and early postpartum) cannot adequately capture the dynamic changes occurring throughout the entire perinatal continuum. Finally, our sample size was calculated based on the primary outcome (change in urinary incontinence symptoms) for a paired analysis. While this sample was sufficient for our primary aim and we detected significant associations for the key outcomes, it may have provided limited power for some complex multivariate analyses. Future larger, multi-centre studies that incorporate more frequent assessments and advanced statistical modelling are needed to fully elucidate the trajectory of maternal health and explore the complex interactions between all potential predictors. Conclusion In conclusion, our study demonstrates that health-related functional impairment is a highly prevalent and impactful dimension of perinatal health that is intricately linked to non-severe maternal morbidities among Chinese women. The findings reveal that a majority of women reported varying degrees of functional impairment, ranging from mild to severe, during both late pregnancy and the postpartum period, with higher levels observed in late pregnancy than at 6 weeks postpartum. Crucially, perinatal health-related functioning is significantly correlated with physical symptoms, anxiety and depression. Furthermore, women with antenatal functional impairment exhibit substantially higher odds of experiencing postpartum functional impairment, physical symptoms, anxiety and depression. The strength of these associations underscores a critical opportunity to improve maternity care. It is important to emphasise that a lack of knowledge and awareness about these conditions may lead to inadequate care and potentially serious short- and long-term health consequences. Therefore, integrating standardised assessments of functioning and mental health into routine perinatal care protocols is not merely a research recommendation but a necessary step toward achieving a more holistic, woman-centred approach to maternity care in China and other global contexts. Moving forward, the provision of targeted health interventions for women with functional impairment, based on comprehensive assessments, will be of paramount importance for promoting maternal health during the perinatal period and beyond.